• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型 B-RAF 调控黑色素瘤中 Rac 依赖性钙黏蛋白转换。

Mutant B-RAF regulates a Rac-dependent cadherin switch in melanoma.

机构信息

1] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA [2] Department of Cell and Developmental Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

出版信息

Oncogene. 2013 Oct;32(40):4836-44. doi: 10.1038/onc.2012.492. Epub 2012 Dec 3.

DOI:10.1038/onc.2012.492
PMID:23208503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4021488/
Abstract

The ability of cells to invade into the dermis is a critical event in the development of cutaneous melanoma and ultimately an indicator of poor prognosis. However, the molecular events surrounding the acquisition of this invasive phenotype remain incompletely understood. Mutations in B-RAF are frequent in melanoma and are known to regulate the invasive phenotype. In this study, we sought to determine the molecular mechanisms controlling melanoma invasion. We found that mutant B-RAF signaling regulates a cadherin switch. In melanoma cells expressing mutant B-RAF we observed high levels of N-cadherin and low levels of E-cadherin. Depletion of mutant B-RAF, by small interfering RNA, caused a decrease in the levels of N-cadherin and an increase in the levels of E-cadherin. Mechanistically, we found that this cadherin switch required the activity of Rac1 and its GEF, Tiam1, both of which show suppressed activity in the presence of mutant B-RAF. Consistent with the work of others, we found that depletion of mutant B-RAF decreased the invasive capacity of the melanoma cells. However, simultaneous depletion of B-RAF and Rac or Tiam1 resulted in invasive capacity similar to that of control cells. Taken together, our results suggest that mutant B-RAF signaling downregulates Tiam1/Rac activity resulting in an increase in N-cadherin levels and a decrease in E-cadherin levels and ultimately enhanced invasion.

摘要

细胞侵入真皮的能力是皮肤黑色素瘤发展的关键事件,最终是预后不良的指标。然而,获得这种侵袭表型的分子事件仍不完全清楚。B-RAF 突变在黑色素瘤中很常见,已知可调节侵袭表型。在这项研究中,我们试图确定控制黑色素瘤侵袭的分子机制。我们发现突变型 B-RAF 信号调节钙粘蛋白开关。在表达突变型 B-RAF 的黑色素瘤细胞中,我们观察到高水平的 N-钙粘蛋白和低水平的 E-钙粘蛋白。通过小干扰 RNA 耗尽突变型 B-RAF 会导致 N-钙粘蛋白水平降低和 E-钙粘蛋白水平升高。从机制上讲,我们发现这种钙粘蛋白开关需要 Rac1 及其 GEF(Tiam1)的活性,在存在突变型 B-RAF 的情况下,两者的活性均受到抑制。与其他人的工作一致,我们发现耗尽突变型 B-RAF 会降低黑色素瘤细胞的侵袭能力。然而,同时耗尽 B-RAF 和 Rac 或 Tiam1 会导致侵袭能力与对照细胞相似。总之,我们的结果表明,突变型 B-RAF 信号下调 Tiam1/Rac 活性,导致 N-钙粘蛋白水平升高和 E-钙粘蛋白水平降低,最终增强侵袭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/3c8a91224b66/nihms549934f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/64b47895d67e/nihms549934f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/27776a88976a/nihms549934f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/7afbb581f0c3/nihms549934f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/450303d34f69/nihms549934f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/98c0ff600a0f/nihms549934f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/d37911800614/nihms549934f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/86c0378cf7a2/nihms549934f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/5a8b3a6a9dcd/nihms549934f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/35b083058928/nihms549934f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/5b13bc6c18af/nihms549934f10a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/3c8a91224b66/nihms549934f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/64b47895d67e/nihms549934f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/27776a88976a/nihms549934f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/7afbb581f0c3/nihms549934f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/450303d34f69/nihms549934f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/98c0ff600a0f/nihms549934f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/d37911800614/nihms549934f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/86c0378cf7a2/nihms549934f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/5a8b3a6a9dcd/nihms549934f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/35b083058928/nihms549934f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/5b13bc6c18af/nihms549934f10a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/4021488/3c8a91224b66/nihms549934f11.jpg

相似文献

1
Mutant B-RAF regulates a Rac-dependent cadherin switch in melanoma.突变型 B-RAF 调控黑色素瘤中 Rac 依赖性钙黏蛋白转换。
Oncogene. 2013 Oct;32(40):4836-44. doi: 10.1038/onc.2012.492. Epub 2012 Dec 3.
2
Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.致癌性 B-RAF(V600E)信号诱导 T-Box3 转录抑制因子抑制 E-钙黏蛋白并增强黑色素瘤细胞侵袭。
J Invest Dermatol. 2013 May;133(5):1269-77. doi: 10.1038/jid.2012.421. Epub 2012 Nov 29.
3
Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensions.Rnd3对肌动蛋白细胞骨架的调节促进黑色素瘤在三维空间中的迁移和侵袭性生长。
Cancer Res. 2009 Mar 15;69(6):2224-33. doi: 10.1158/0008-5472.CAN-08-3201. Epub 2009 Feb 24.
4
Rac is a dominant regulator of cadherin-directed actin assembly that is activated by adhesive ligation independently of Tiam1.Rac是一种主导性的钙黏蛋白导向的肌动蛋白组装调节因子,它可通过黏附连接被激活,且不依赖于Tiam1。
Am J Physiol Cell Physiol. 2007 Mar;292(3):C1061-9. doi: 10.1152/ajpcell.00073.2006. Epub 2006 Oct 4.
5
Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.突变型V599EB-Raf调节恶性黑色素瘤肿瘤的生长和血管发育。
Cancer Res. 2005 Mar 15;65(6):2412-21. doi: 10.1158/0008-5472.CAN-04-2423.
6
Mutant B-Raf(V600E) Promotes Melanoma Paracellular Transmigration by Inducing Thrombin-mediated Endothelial Junction Breakdown.突变型B-Raf(V600E)通过诱导凝血酶介导的内皮细胞连接破坏促进黑色素瘤旁细胞迁移。
J Biol Chem. 2016 Jan 29;291(5):2087-106. doi: 10.1074/jbc.M115.696419. Epub 2015 Oct 26.
7
Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.使用纳米脂质体小干扰RNA靶向V600EB-Raf和Akt3可抑制皮肤黑素细胞病变的发展。
Cancer Res. 2008 Sep 15;68(18):7638-49. doi: 10.1158/0008-5472.CAN-07-6614.
8
FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.FOXD3 是一种突变的 B-RAF 调节因子,可抑制黑色素瘤细胞中的 G(1)-S 期进展。
Cancer Res. 2010 Apr 1;70(7):2891-900. doi: 10.1158/0008-5472.CAN-09-3139. Epub 2010 Mar 23.
9
Mutant B-RAF mediates resistance to anoikis via Bad and Bim.突变型B-RAF通过Bad和Bim介导对失巢凋亡的抗性。
Oncogene. 2008 May 22;27(23):3301-12. doi: 10.1038/sj.onc.1211003. Epub 2008 Feb 4.
10
Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases.靶向突变型(V600E)B-Raf信号级联中的丝裂原活化蛋白激酶/细胞外信号调节激酶激酶可有效抑制黑色素瘤肺转移。
Cancer Res. 2006 Aug 15;66(16):8200-9. doi: 10.1158/0008-5472.CAN-06-0809.

引用本文的文献

1
Targeting the Hippo Pathway in Cutaneous Melanoma.靶向皮肤黑色素瘤中的 Hippo 通路。
Cells. 2024 Jun 19;13(12):1062. doi: 10.3390/cells13121062.
2
Skin Cancers and the Contribution of Rho GTPase Signaling Networks to Their Progression.皮肤癌以及Rho GTPase信号网络在其进展中的作用。
Cancers (Basel). 2021 Aug 28;13(17):4362. doi: 10.3390/cancers13174362.
3
Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.细胞重编程——黑色素瘤细胞可塑性模型

本文引用的文献

1
Time-resolved human kinome RNAi screen identifies a network regulating mitotic-events as early regulators of cell proliferation.时间分辨的人类蛋白质组 RNAi 筛选鉴定了一个调节有丝分裂事件的网络,作为细胞增殖的早期调控因子。
PLoS One. 2011;6(7):e22176. doi: 10.1371/journal.pone.0022176. Epub 2011 Jul 13.
2
Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A.致癌 BRAF 通过下调 cGMP 特异性磷酸二酯酶 PDE5A 诱导黑素瘤细胞侵袭。
Cancer Cell. 2011 Jan 18;19(1):45-57. doi: 10.1016/j.ccr.2010.10.029. Epub 2011 Jan 6.
3
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma.
Int J Mol Sci. 2020 Nov 5;21(21):8274. doi: 10.3390/ijms21218274.
4
Molecular pathology of cutaneous melanoma.皮肤黑色素瘤的分子病理学
Melanoma Manag. 2014 Nov;1(2):151-164. doi: 10.2217/mmt.14.23. Epub 2014 Dec 4.
5
ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant Melanoma.ERK/MAPK信号通路驱动Rac鸟苷酸交换因子PREX1在BRAF和NRAS突变型黑色素瘤中过表达。
Mol Cancer Res. 2016 Oct;14(10):1009-1018. doi: 10.1158/1541-7786.MCR-16-0184. Epub 2016 Jul 14.
6
Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Upregulation of antioxidant genes correlates with regression of melanoma malignancy and with malignant progression when downregulated.通过过氧化氢酶过表达对人A375无黑色素黑色素瘤细胞进行重编程:抗氧化基因的上调与黑色素瘤恶性程度的消退相关,而下调时则与恶性进展相关。
Oncotarget. 2016 Jul 5;7(27):41154-41171. doi: 10.18632/oncotarget.9273.
7
SPARC Controls Melanoma Cell Plasticity through Rac1.富含半胱氨酸的酸性分泌蛋白(SPARC)通过Rac1控制黑色素瘤细胞的可塑性。
PLoS One. 2015 Aug 6;10(8):e0134714. doi: 10.1371/journal.pone.0134714. eCollection 2015.
8
IRGM1 enhances B16 melanoma cell metastasis through PI3K-Rac1 mediated epithelial mesenchymal transition.IRGM1通过PI3K-Rac1介导的上皮-间质转化增强B16黑色素瘤细胞转移。
Sci Rep. 2015 Jul 23;5:12357. doi: 10.1038/srep12357.
9
Melanoma: clinical features and genomic insights.黑色素瘤:临床特征与基因组学见解
Cold Spring Harb Perspect Med. 2014 Sep 2;4(9):a015388. doi: 10.1101/cshperspect.a015388.
10
ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer models.ROBO1,一种肿瘤抑制因子,是局部肿瘤细胞获得侵袭性表型的关键分子屏障:在非裔美国人和白种人前列腺癌模型中的研究
Int J Cancer. 2014 Dec 1;135(11):2493-506. doi: 10.1002/ijc.28919. Epub 2014 Apr 29.
RAF 抑制剂的临床疗效需要在 BRAF 突变型黑色素瘤中广泛的靶标阻断。
Nature. 2010 Sep 30;467(7315):596-9. doi: 10.1038/nature09454.
4
Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensions.Rnd3对肌动蛋白细胞骨架的调节促进黑色素瘤在三维空间中的迁移和侵袭性生长。
Cancer Res. 2009 Mar 15;69(6):2224-33. doi: 10.1158/0008-5472.CAN-08-3201. Epub 2009 Feb 24.
5
Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma.Snail对CYLD表达的下调促进恶性黑色素瘤的肿瘤进展。
J Exp Med. 2009 Jan 16;206(1):221-32. doi: 10.1084/jem.20082044. Epub 2009 Jan 5.
6
Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.Brn-2抑制小眼畸形相关转录因子的表达,并标记小眼畸形相关转录因子阴性黑色素瘤细胞的一个独特亚群。
Cancer Res. 2008 Oct 1;68(19):7788-94. doi: 10.1158/0008-5472.CAN-08-1053.
7
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity.发现一种具有强大抗黑色素瘤活性的致癌性B-Raf激酶选择性抑制剂。
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3041-6. doi: 10.1073/pnas.0711741105. Epub 2008 Feb 19.
8
B-RAF regulation of Rnd3 participates in actin cytoskeletal and focal adhesion organization.B-RAF对Rnd3的调控参与肌动蛋白细胞骨架和粘着斑组织的形成。
Mol Biol Cell. 2008 Feb;19(2):498-508. doi: 10.1091/mbc.e07-09-0895. Epub 2007 Nov 28.
9
MEK/ERK regulates adherens junctions and migration through Rac1.丝裂原活化蛋白激酶/细胞外信号调节激酶通过Rac1调节黏着连接和细胞迁移。
Cell Motil Cytoskeleton. 2007 Mar;64(3):143-56. doi: 10.1002/cm.20172.
10
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling.在黑色素瘤中,RAS突变伴随着信号传导从BRAF转换为CRAF以及环磷酸腺苷信号传导的破坏。
Cancer Res. 2006 Oct 1;66(19):9483-91. doi: 10.1158/0008-5472.CAN-05-4227.